The Oncology Institute, Inc. Common Stock Stock Prediction
AI-powered sentiment analysis and prediction trends for TOI, updated each market day.
TOI AI Sentiment
AI sees no strong directional signal for The Oncology Institute, Inc. Common Stock stock over the next 10 market days.
Prediction date: April 10, 2026
Subscribers see precise scores, buy/sell targets, and full analytics.
About The Oncology Institute, Inc. Common Stock
The Oncology Institute Inc offers oncology care and treatment services to patients through several clinics located across the United States. It offers services such as infusion chemotherapy, oral drug chemotherapy, hospice and palliative care, autologous stem cell transplants, outpatient blood product transfusions, patient navigator programs, radiation oncology, and others on a fee or value-based model. Additionally, the company enrolls patients in clinical trials, where appropriate. The company has three operating segments: Specialty Pharmacy, Patient Services, and Clinical Trials and Other. Maximum revenue is generated from the Specialty Pharmacy segment, which operates specialty and retail pharmacies providing IV-infused, oral, injectable, and other medications for oncology treatment.
Sector
Exchange
Market Cap
$307,389,737
Cap Tier
Employees
641
Headquarters
CERRITOS, CA
Listed Since
Nov. 15, 2021
TOI Sentiment Trend — Last 30 Predictions
Sentiment zones: Bullish · Neutral · Bearish
TOI Volatility
The Oncology Institute, Inc. Common Stock has shown high price volatility over the last 5 trading days. High volatility means larger price swings — this can present both opportunity and risk for traders.
